1. Zhang, Qinzhen, Xia, Tianxiang, Qi, Chenxiang, Du, Jun, Ye, Chunping. 2022. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. In BMC cancer, 22, 77. doi:10.1186/s12885-022-09180-5. https://pubmed.ncbi.nlm.nih.gov/35042454/
2. Lapi, E, Iovino, A, Fontemaggi, G, Blandino, G, Strano, S. 2006. S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation. In Oncogene, 25, 3628-37. doi:. https://pubmed.ncbi.nlm.nih.gov/16449968/
3. Nagy, N, Brenner, C, Markadieu, N, Kiss, R, Decaestecker, C. . S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. In Laboratory investigation; a journal of technical methods and pathology, 81, 599-612. doi:. https://pubmed.ncbi.nlm.nih.gov/11304580/
4. Buckley, N E, D'Costa, Z, Kaminska, M, Mullan, P B. 2014. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. In Cell death & disease, 5, e1070. doi:10.1038/cddis.2014.31. https://pubmed.ncbi.nlm.nih.gov/24556685/
5. Yan, Jia, Huang, Ya Jun, Huang, Qing Yu, Liu, Peng Xia, Wang, Chang Shan. 2022. Transcriptional activation of S100A2 expression by HIF-1α via binding to the hypomethylated hypoxia response elements in HCC cells. In Molecular carcinogenesis, 61, 494-507. doi:10.1002/mc.23393. https://pubmed.ncbi.nlm.nih.gov/35107180/
智鼠故事 
